Brookelyn Morgan told Newsweek that her vet told her: "That is just how he is built, tell people he goes to the gym!" ...

Corcept Therapeutics (NASDAQ: CORT) and Amicus Therapeutics (NASDAQ: FOLD) delivered Q3 2025 results highlighting two rare ...

Cushing's syndrome is a relatively rare medical disorder, and yet around 10 to 15 million new cases are diagnosed in the US ...

Dechra announced earlier today that it has received approval from the FDA for its pergolide tablets (Zygolide; Dechra) to ...

The FDA has approved pergolide tablets (Zygolide; Dechra) for controlling clinical signs associated with pituitary pars intermedia dysfunction (PPID) in horses, also known as equine Cushing disease.

Crinetics Pharmaceuticals reported positive topline results from Phase 2 studies of atumelnant for CAH and ACTH-dependent Cushing's syndrome.

The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections for the companies’ respective drug applications. Sanofi revealed Dec. 24 that the ...

Amy Schumer is clearing up speculation over her recent 50-pound weight loss. The comedian stated in a social media post that she didn't undergo the transformation "to look hot, which does feel fun and ...

Recorlev is a prescription oral tablet that’s used in certain adults with Cushing syndrome. The drug is typically taken twice per day (every 12 hours). Recorlev can interact with other drugs, ...

There is currently "no role" for hormone panel testing to guide therapy for menopausal symptoms as it doesn't improve care, editorialists argued in The BMJ. Intraoperative parathyroid hormone ...

"[The study] findings provide further evidence of the need for rigorous thromboprophylaxis in patients with CD [Cushing disease] from the time of diagnosis and subsequently throughout the ...

DOYLESTOWN, Pa., June 24, 2025 /PRNewswire/ -- Sterotherapeutics LLC, a clinical-stage biopharmaceutical company focused on rare endocrine diseases, today announced that the first patient has been ...